Literature DB >> 18427603

Occurrence of giant cell arteritis...suddenly.

Brian R Younge1, Cornelia M Weyand, Jorg J Goronzy.   

Abstract

PURPOSE: To define the kinetics and mechanisms of frank arteritis onset in patients with giant cell arteritis.
METHODS: Cytokines were analyzed from tissue of a patient before and after the development of arteritis.
RESULTS: A temporal artery biopsy specimen from a patient with giant cell arteritis showed no pathologic changes on microscopic examination, but there was evidence of early tissue activation of inflammatory markers. A specimen from the contralateral artery 12 days later had high levels of IL-18 transcripts and abundant transcripts for CCL19. Also, CD83 and IL-1 were present, confirming that the vascular dendritic cells had fully matured. This second biopsy specimen showed floridly positive giant cell arteritis on histopathologic examination.
CONCLUSIONS: Partial activation of vascular dendritic cells is typically seen in patients with polymyalgia rheumatica in whom no inflammatory infiltrates are seen on histomorphologic examination. Dendritic cells become activated at an early stage of arteritis, beginning the pathologically evident arteritis, and are fully matured in microscopically florid arteritis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18427603      PMCID: PMC2258118     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  10 in total

1.  Thrombocytosis in patients with biopsy-proven giant cell arteritis.

Authors:  Rod Foroozan; Helen Danesh-Meyer; Peter J Savino; Greg Gamble; Omar N Mekari-Sabbagh; Robert C Sergott
Journal:  Ophthalmology       Date:  2002-07       Impact factor: 12.079

2.  POLYMYALGIA RHEUMATICA. A FORM OF SENILE ARTERITIS?

Authors:  B OLHAGEN
Journal:  Acta Rheumatol Scand       Date:  1963

3.  Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.

Authors:  Mehrdad Mazlumzadeh; Gene G Hunder; Kirk A Easley; Kenneth T Calamia; Eric L Matteson; W Leroy Griffing; Brian R Younge; Cornelia M Weyand; Jörg J Goronzy
Journal:  Arthritis Rheum       Date:  2006-10

4.  Giant cell vasculitis is a T cell-dependent disease.

Authors:  A Brack; A Geisler; V M Martinez-Taboada; B R Younge; J J Goronzy; C M Weyand
Journal:  Mol Med       Date:  1997-08       Impact factor: 6.354

5.  Thrombocytosis in temporal arteritis rising platelet counts: a red flag for giant cell arteritis.

Authors:  N S Lincoff; P D Erlich; L S Brass
Journal:  J Neuroophthalmol       Date:  2000-06       Impact factor: 3.042

6.  Polymyalgia arteritica.

Authors:  B Hamrin
Journal:  Acta Med Scand Suppl       Date:  1972

7.  Disease patterns and tissue cytokine profiles in giant cell arteritis.

Authors:  C M Weyand; N Tetzlaff; J Björnsson; A Brack; B Younge; J J Goronzy
Journal:  Arthritis Rheum       Date:  1997-01

8.  Thrombokinetics in giant cell arteritis, with special reference to corticosteroid therapy.

Authors:  A L Bergström; B A Bengtsson; L B Olsson; B E Malmvall; J Kutti
Journal:  Ann Rheum Dis       Date:  1979-06       Impact factor: 19.103

9.  Giant cell arteritis. Clinical features and involvement of different organs.

Authors:  B E Malmvall; B A Bengtsson
Journal:  Scand J Rheumatol       Date:  1978       Impact factor: 3.641

10.  Initiation of glucocorticoid therapy: before or after temporal artery biopsy?

Authors:  Brian R Younge; Briggs E Cook; George B Bartley; David O Hodge; Gene G Hunder
Journal:  Mayo Clin Proc       Date:  2004-04       Impact factor: 7.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.